Marie-Aleth Richard
Overview
Explore the profile of Marie-Aleth Richard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tedbirt B, Houivet E, Maho-Vaillant M, Golinski M, Calbo S, Prost-Squarcioni C, et al.
JAMA Dermatol
. 2025 Mar;
PMID: 40042819
No abstract available.
2.
Passeron T, Fontas E, Boye T, Richard M, Delaporte E, Dereure O
JID Innov
. 2024 Sep;
4(6):100307.
PMID: 39310808
Rationale: Experimental data support the role for C5a-C5aR1 axis activation in bullous pemphigoid. We assessed the efficacy and safety of avdoralimab, a specific anti-C5aR1 mAb, for treating bullous pemphigoid. Methods:...
3.
Misery L, Seneschal J, Corgibet F, Halioua B, Sampogna F, Merhand S, et al.
Clin Exp Dermatol
. 2024 Sep;
50(2):422-423.
PMID: 39229930
No abstract available.
4.
Walsh S, Richard M
J Eur Acad Dermatol Venereol
. 2024 Jul;
38(8):1451-1452.
PMID: 39049765
No abstract available.
5.
Lim H, Saint Aroman M, Skayem C, Halioua B, Perez Cullell N, Ben Hayoun Y, et al.
J Eur Acad Dermatol Venereol
. 2024 May;
38(10):2024-2033.
PMID: 38738687
Background: As exposure to UV radiation is the primary modifiable environmental risk factor associated with skin cancer, it remains the principal focus of most prevention strategies. Numerous sun protection campaigns...
6.
Monnier J, Foahom Gouabou A, Serdi M, Collenne J, Iguernaissi R, Richard M, et al.
J Am Acad Dermatol
. 2024 Apr;
91(2):350-352.
PMID: 38614250
No abstract available.
7.
Marty T, Khadar M, Autelitano L, Baissac C, Mebarki A, Texier N, et al.
J Eur Acad Dermatol Venereol
. 2024 Feb;
38(7):1373-1382.
PMID: 38314863
Background: Dermatoses represent a significant burden. Patients and their caregivers can turn to social media and digital communities to exchange with each other. These public exchanges constitute real-life data that...
8.
Collenne J, Monnier J, Iguernaissi R, Nawaf M, Richard M, Grob J, et al.
J Invest Dermatol
. 2024 Jan;
144(7):1600-1607.e2.
PMID: 38296020
Melanoma is still a major health problem worldwide. Early diagnosis is the first step toward reducing its mortality, but it remains a challenge even for experienced dermatologists. Although computer-aided systems...
9.
Tedbirt B, Maho-Vaillant M, Houivet E, Mignard C, Golinski M, Calbo S, et al.
JAMA Dermatol
. 2024 Jan;
160(3):290-296.
PMID: 38265821
Importance: The Ritux 3 trial demonstrated the short-term efficacy and safety of first-line treatment with rituximab compared with a standard corticosteroid regimen in pemphigus. No data on the long-term follow-up...
10.
Halioua B, Le Roux-Villet C, Baissac C, Ben Hayoun Y, Perez-Cullell N, Taieb C, et al.
J Eur Acad Dermatol Venereol
. 2023 Nov;
38(5):e401-e403.
PMID: 37909319
No abstract available.